Published in
American Association for the Advancement of Science, Science Translational Medicine, 580(13), 2021
DOI: 10.1126/scitranslmed.abd7064
Links
Tools
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Journal article published in 2021 by
Mahmoud Abdellatif 
,
Viktoria Trummer-Herbst ,
Franziska Koser,
Sylvère Durand,
Rui Adão ,
Francisco Vasques-Nóvoa ,
Johanna K. Freundt,
Julia Voglhuber ,
Maria-Rosaria Pricolo ,
Michael Kasa ,
Clara Türk ,
Fanny Aprahamian,
Elías Herrero-Galán ,
Sebastian J. Hofer ,
Tobias Pendl
and other authors.
,
Viktoria Trummer-Herbst ,
Franziska Koser,
Sylvère Durand,
Rui Adão ,
Francisco Vasques-Nóvoa ,
Johanna K. Freundt,
Julia Voglhuber ,
Maria-Rosaria Pricolo ,
Michael Kasa ,
Clara Türk ,
Fanny Aprahamian,
Elías Herrero-Galán ,
Sebastian J. Hofer ,
Tobias Pendl
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
The NAD + precursor nicotinamide improves diastolic dysfunction caused by aging, hypertension, or metabolic syndrome in rodents.